Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

January 28, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Uterine Cervical NeoplasmsCervical Cancer
Interventions
DRUG

Paclitaxel or docetaxel + Cisplatin or carboplatin

Paclitaxel 135-175mg/m2 over 3 hours or docetaxel 70-75 mg/m2, 30min + Cisplatin 75-80mg/m2 or carboplatin AUC = 5, repeat per 21 days.

Trial Locations (3)

250012

Qilu Hospital, Shandong University, 107 West Wenhua Road, Ji'nan

310022

Women's Hospital, Zhejiang University School of Medicine, Hangzhou

430000

Tongji Hospital, Wuhan

All Listed Sponsors
collaborator

Women's Hospital School Of Medicine Zhejiang University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Obstetrics & Gynecology Hospital of Fudan University

OTHER

collaborator

First Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Hunan Cancer Hospital

OTHER

collaborator

The Third Xiangya Hospital of Central South University

OTHER

lead

Huazhong University of Science and Technology

OTHER